Our leadership team
Mr. Ziv Turner
Chairman & CEO
Mr. Ziv Turner
Mr. Shmuel De-Saban
CFO and board member
Mr. Shmuel De-Saban
Shmuel De-Saban, age 54, a CPA, has operated his own accounting firm for the past 11 years, providing complete accounting services to clients including the establishment of internal management reports, examining all corporate systems such as: (i) purchase management (inventory and procurement planning); (ii) cash flow, work plans, annual budgets, and monthly analysis of performance against budget; and (iii) establishment of working procedures, among other related accounting services. De-Saban’s CPA has represented both Israeli and international clients engaged in manufacturing, importers, foreign and domestic residents, real estate, financial services and healthcare.
Mr. De-Saban has acted as CFO of OWC pharmaceutical research corp. and OWC Israel starting 6/16/2014 and until 6/12/2017. During this period, Mr. De-Saban has continuously reported to the SEC all needed reports.
Mr. De-Saban studied for a Bachelor’s Degree in Economics at Tel-Aviv University and a degree as a CPA from Bar-Ilan university.
Dr. Med. Yehuda Baruch
Chief Medical and Regulatory Officer
Dr. Med. Yehuda Baruch
Chief Medical and Regulatory Officer
Dr. Yehuda Baruch served as Head of the Israeli Ministry of Health’s Medical Marijuana Program from 2003 through 2013 where he spearheaded the efforts on regulation, chaired the indication committee, secured Helsinki Approvals for medical research, and managed regulation of patient licensing and dosage. He has extensive experience in researching medical cannabis, most notably for its effect on PTSD.
From 2004 until recently he served as CEO of Abarbanel Mental Health Center in Bat Yam, Israel. Prior to that, he was the director of Israel’s Ministry of Health medical management division, and director general of Be’er Yakov Mental Health Center. He has taught at Ben-Gurion University of the Negev and Tel Aviv University’s Sackler School of Medicine.
Mr. Amir Ohad
Financial advisor to the board
Mr. Amir Ohad
Mr. Amir Ohad, age 57, has served as the Chairman of OHK Medical Devices, Inc., a company which manufactures and sells innovative orthopedic and vascular surgery products, since 2015. Mr. Ohad also serves as a director of Massivit 3D Printing Technologies Ltd. and iSonea (Israel) Ltd.
Mr. Ohad has served as an associate in the International Institute for Counter-Terrorism at the Interdisciplinary Academic Institution in Hertzeliya, Israel since 2017. Mr. Ohad served more than 25 years of as a senior executive in private and public companies. From 2005 to 2007, Mr. Ohad served as the chief executive officer of Alqemia Group (Kafrit Industries), a publicly traded specialty compounding firm and served as the chief financial officer of ScitexVision (acquired by Hewlett Packard in 2005) from 2000 to 2005.
Mr. Zvi Riterband
Financial advisor to the board
Mr. Zvi Riterband
Mr. Zvi Riterband, age 59, specializes in optimization of company rights and assets in multi jurisdiction companies. Mr. Riterband served as director and CEO of EZTD, Inc. from 2017 to 2020 and served as General Manager of AMERIS Holdings Ltd. from 2015 to 2017.
Mr. Riterband completed his studies at the Technion – Israel Institute of Technology and has 25 years of experience managing international companies in the industrial and financial sectors including public held companies as Chip P.C. Ltd, Nia, Sefen, Transtech Airport Solutions and Bikur Cholim Hospital in Jerusalem.
Dr. Gila Shimoni
Patents Advisor to the Board
Dr. Gila Shimoni
Dr. Gila Shimoni is a licensed Patent Attorney and the manager of the Chemistry, Pharmacology and Biotech affairs at Richter & Shimoni.
Gila’s professional experience encompasses advising on patent portfolio strategy and drafting of patentability and freedom to operate opinions. Gila’s legal work further includes the drafting and prosecution of hundreds of Pharmaceutical, Chemistry, Aggrotech, and Biotech patent applications with particular emphasis in the organic chemistryy and formulation areas.
Gila has been providing legal services to dozens of clients which include leading universities and research institutes, chemical and pharmaceutical companies, start-ups and private clientele.
Gila holds a B.Sc. and M.Sc. in Chemistry from Ben Gurion University, and a Ph.D. in Biophysics from the Hebrew University of Jerusalem. After completing her Ph.D., Gila pursued her Post-doctoral project at the Weizmann Institute of Science, Israel.
